|
Market Cap (1-Jul) $77,044,616 (564th) |
Close (30-Jun) $0.180 |
Volume (30-Jun) 3,225,766 |
Shortsold (19-Jun) 12,988,365 (0.64%) (278th) |
|
52w High $0.073 |
52w Low $0.026 |
P/E - |
EPS -0.01 |
IPD released this announcement to the ASX on 6 October 2022, 15:51. The announcement is not marked as price sensitive, and is 7 page(s) in length and 26.21kb in size.
You can view all announcements from IPD and see how they appear on a price chart on the announcements page.
At the date of this announcement, IPD was 0.195% short sold according to ASIC data. It was ranked the 436th most shorted stock on the ASX. It is now ranked as the 278th most shorted stock on the ASX with 0.641% of total shares short sold as of the latest reported data (19 June 2025).
| Other Recent Announcements from IPD | |
|---|---|
| Revised Security Trading Policy | 30 June 2023, 8:18 |
| ImpediMed Achieves Critical Mass in First Key Target State | 29 June 2023, 9:32 |
| ImpediMed Updates Board for Growth in Oncology | 28 June 2023, 8:22 |
| Application for quotation of securities - IPD | 6 October 2022, 15:51 |
| New Corporate Oncology Account with GenesisCare | 4 October 2022, 8:12 |
| Notice of Annual General Meeting & Voting Form | 23 September 2022, 8:11 |
| Notification regarding unquoted securities - IPD | 13 September 2022, 12:20 |
You must be logged in to post a reply.
ImpediMed 